A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status:
Completed
Trial end date:
2019-04-10
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy on abdominal symptoms (abdominal bloating, abdominal discomfort, and
abdominal pain) and safety of linaclotide 290 μg administered orally to patients with IBS-C.